The document outlines key points from a presentation on hypertension given by Dr. Jafar Alsaid at the Iraqi Hypertension Conference in November 2021. It discusses the global burden of hypertension, challenges in low-income countries, definitions and classifications of hypertension, measuring blood pressure, common risk factors, target organ damage, lifestyle modifications, pharmacological treatments, and the importance of patient education.
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
Â
International Society of Hypertension 2020 guidlines
1. JAFAR ALSAID M.B.ChB. MD. FASN. FACP.
Chair of the Middle East and North Africa Advisory Group. ISH
Nephrology Consultant. Ochsner Health System. USA
Nephrology and Internal Medicine Consultant. Bahrain
jafaralsaid@gmail.com
2020 INTERNATIONAL SOCIETY OF HYPERTESION
GLOBAL HYPERTENSION PRACTICE GUIDLINES.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
1
3. Introduction
Hypertension
⢠Leading cause of death.
⢠10.4 million death annually.
⢠Affect 1.39 Billion people.
⢠More in the low-income countries.
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension prevalence
and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441â450.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
3
4. Awareness
67%
38%
High Income Low and Middle Income
Beaney T, Burrell LM, Castillo RR, Charchar FJ, Cro S, Damasceno A, Kruger R, Nilsson PM, Prabhakaran D, Ramirez AJ, et al,
MMM Investigators. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood
pressure by the International Society of Hypertension. Eur Heart J. 2019;40:2006â2017.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
4
5. INTERNATIONAL SOCIETY OF HYPERTENSION
HYPERTENSION GLOBAL AWARENESS CAMPAGN
MAY MEASUREMENT MONTH INITIATIVE
MMM
Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, Charchar FJ, Damasceno A, Kruger R, Lackland DT,
et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health.
2018;6:e736-e743.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
5
7. Obstacles for Low-income countries:
⢠No regional guidelines.
⢠Lack of data in low-income countries.
⢠Availability of multiple guidelines.
⢠Difficulties in following high income countries guidelines.
⢠Guidelines generated reflect the best practice for that
population.
⢠Lack of trained health facilities.
⢠Low access to basic BP devices.
Poulter NR, Castillo R, Charchar FJ, Schlaich MP, Schutte AE, Tomaszewski M, Touyz RM, Wang JG. Are the American Heart
Association/ American College of Cardiology high blood pressure guidelines fit for global purpose?: Thoughts from the
International Society of Hypertension. Hypertension. 2018;72:260â262.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
7
12. Points to consider on Measuring BP
⢠Repeat the reading.
⢠Both arms are checked. >10mmHg is significant.
⢠Standing BP. In Orthostatic symptoms.
⢠BP Cuff size.
⢠Unattended Office BP.
⢠Out of office BP measurements.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
13
13. White Coat & Masked Hypertension
White Coat Masked
% 10-30 10-15
Clinic/Hospital Elevated Normal
Out of office BP Normal Elevated
CV risk Moderate Like HTN
Diagnosis ABPM/Home
Management Lifestyle Lifestyle + Med.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et
al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management Of Arterial
Hypertension of the European Society of Cardiology and the
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
14
15. CV risk factors with HTN
⢠DM 15-20%.
⢠Elevated LDL and Triglyce. 30%.
⢠Over wt. 40%.
⢠Hyperuricemia. 25%
⢠Metabolic syndrome. 40%
⢠Unhealthy lifestyle.
⢠Family history.
⢠Age/Gender/Race.
⢠Chronic Inflammation.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of
population health data. Lancet. 2006;367:1747â1757.
Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings
and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992;152:56â64
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
16
16. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al.
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management Of Arterial
Hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953â2041.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
17
17. Hypertension
Mediated
Organ
Damage
Brain: Stroke, Microinfarct, Bleed or
Atrophy.
Heart: LVH. Diastolic or systolic dysfunction.
Kidney: Proteinuria or decreased eGFR.
Vascular system: Central or Peripheral.
Eye: Retinal changes. Papilledema.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
18